151 related articles for article (PubMed ID: 8702488)
21. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa.
Pulkkinen L; Christiano AM; Airenne T; Haakana H; Tryggvason K; Uitto J
Nat Genet; 1994 Mar; 6(3):293-7. PubMed ID: 8012393
[TBL] [Abstract][Full Text] [Related]
22. Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.
Baudoin C; Miquel C; Blanchet-Bardon C; Gambini C; Meneguzzi G; Ortonne JP
J Clin Invest; 1994 Feb; 93(2):862-9. PubMed ID: 8113417
[TBL] [Abstract][Full Text] [Related]
23. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Calos MP; Khavari PA
Hum Gene Ther; 2003 Jun; 14(9):923-8. PubMed ID: 12828862
[TBL] [Abstract][Full Text] [Related]
24. Biological function of laminin-5 and pathogenic impact of its deficiency.
Schneider H; Mühle C; Pacho F
Eur J Cell Biol; 2007 Dec; 86(11-12):701-17. PubMed ID: 17000025
[TBL] [Abstract][Full Text] [Related]
25. Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.
Mühle C; Jiang QJ; Charlesworth A; Bruckner-Tuderman L; Meneguzzi G; Schneider H
Hum Genet; 2005 Jan; 116(1-2):33-42. PubMed ID: 15538630
[TBL] [Abstract][Full Text] [Related]
26. The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion.
Gagnoux-Palacios L; Allegra M; Spirito F; Pommeret O; Romero C; Ortonne JP; Meneguzzi G
J Cell Biol; 2001 May; 153(4):835-50. PubMed ID: 11352943
[TBL] [Abstract][Full Text] [Related]
27. Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa.
Meng X; Klement JF; Leperi DA; Birk DE; Sasaki T; Timpl R; Uitto J; Pulkkinen L
J Invest Dermatol; 2003 Oct; 121(4):720-31. PubMed ID: 14632187
[TBL] [Abstract][Full Text] [Related]
28. LAMB3 gene transfection into SV40-transformed keratinocytes from patient with Herlitz junctional epidermolysis bullosa.
Masunaga T; Shimizu H; Matsui C; Aozaki R; Morohashi M; Yasumoto S; Nishikawa T
Arch Dermatol Res; 2000 Apr; 292(4):195-7. PubMed ID: 10836613
[No Abstract] [Full Text] [Related]
29. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
Jeon IK; Kim SE; Kim SC
J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
[TBL] [Abstract][Full Text] [Related]
30. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
Meneguzzi G; Marinkovich MP; Aberdam D; Pisani A; Burgeson R; Ortonne JP
Exp Dermatol; 1992 Dec; 1(5):221-9. PubMed ID: 1365323
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation.
Spirito F; Chavanas S; Prost-Squarcioni C; Pulkkinen L; Fraitag S; Bodemer C; Ortonne JP; Meneguzzi G
J Biol Chem; 2001 Jun; 276(22):18828-35. PubMed ID: 11279058
[TBL] [Abstract][Full Text] [Related]
32. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
[TBL] [Abstract][Full Text] [Related]
33. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
[TBL] [Abstract][Full Text] [Related]
34. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells.
Ryan MC; Lee K; Miyashita Y; Carter WG
J Cell Biol; 1999 Jun; 145(6):1309-23. PubMed ID: 10366601
[TBL] [Abstract][Full Text] [Related]
35. Amino acid substitution in the C-terminal domain of collagen XVII reduces laminin-332 interaction causing mild skin fragility with atrophic scarring.
Kroeger J; Hoppe E; Galiger C; Has C; Franzke CW
Matrix Biol; 2019 Jul; 80():72-84. PubMed ID: 30316981
[TBL] [Abstract][Full Text] [Related]
36. Junctional epidermolysis bullosa keratinocytes in culture display adhesive, structural, and functional abnormalities.
Krueger JG; Lin AN; Leong I; Carter DM
J Invest Dermatol; 1991 Nov; 97(5):849-61. PubMed ID: 1717612
[TBL] [Abstract][Full Text] [Related]
37. Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa.
Robbins PB; Sheu SM; Goodnough JB; Khavari PA
Hum Gene Ther; 2001 Jul; 12(11):1443-8. PubMed ID: 11485635
[TBL] [Abstract][Full Text] [Related]
38. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
[TBL] [Abstract][Full Text] [Related]
39. The alpha-3 polypeptide chain of laminin 5: insight into wound healing responses from the study of genodermatoses.
Hamill KJ; McLean WH
Clin Exp Dermatol; 2005 Jul; 30(4):398-404. PubMed ID: 15953081
[TBL] [Abstract][Full Text] [Related]
40. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]